
Havenor Therapeutics · Its newest medicine, Avericin, is finished and waiting for a health authority to approve it.
Task 06 · Validation Engineer
Check the container-closure validation records
Check what in the bag-system validation package would not stand if a reviewer examined it.
Claude Opus 5 caught 5 of 9 traps. See which →
3What just happened?
Havenor is about to show the regulator the studies proving its bag system is safe.
The bag, ports and wrapper must keep the medicine sterile and must not leak chemicals into it. Three reports claim to prove this. Before the meeting, someone must check whether they’d hold up.
4Who has to do what?
Check what in the bag-system validation package would not stand if a reviewer examined it.
- The seat
- Asha Morgan, Validation Engineer
- What a good answer looks like
- It finds the paperwork defects an inspector would notice: missing protocols, copy-pasted reports, unknown signers, phantom documents, recycled figures.
- What must be handed in
AVI-401_ccs_validation_records_check.docx
The assignment as the model received it
Assess whether the filed container-closure evidence can withstand review and state the unresolved gates without rewriting controlled evidence.
5Which files decide it?
Three container-system reports, the company roster, the document catalogue, and the filter studies for comparison.
The model also has the rest of the company’s shared drive, its chat and its record systems. Finding the right files is part of the job. Flip through the key ones below.
Company documents
Some of the documents available to the model.
What was actually done?
The validation package includes plans, a scanned executed copy, and a report. The reviewer has to reconcile all three.
The model must check whether the work recorded in the protocol supports the report’s conclusions.

6What did the model do?
What Claude Opus 5 did, step by step.
In short: Opus views the scanned executed protocols and calibration certificates and finds that the container-closure studies have no protocols or executed records behind them.
Step 6. Reads the container-closure reports. Every report names a reviewer and approver who are not in the company roster. Opus reads these signature blocks but does not check them against the roster.
Report text read by the modelReviewed by Marta Ibrahim, Validation Engineer
Bears on: Signers who don’t work here
Step 67. Finds no protocols behind the studies. Opus compares the container-closure studies with the filter studies and finds that only the filter studies have approved protocols and executed copies.
Text written into the check2.1 The three CCS studies have no protocol and no executed record on file
Replay every step of the run →
Inside the run
Reads the container-closure reports
Reviewed by Marta Ibrahim, Validation Engineer
Every report names a reviewer and approver who are not in the company roster. Opus reads these signature blocks but does not check them against the roster.
7Which traps did it catch?
It caught 5 of 9.
Specialists wrote these checks from the real records before any model ran. Each is a weak spot a reviewer or inspector would find. A check passes only if the handed-in file states it.
Missed
Test conditions are vague R03
The reports say only “routine time + 20%”, with no actual infusion time, tubing materials or leachable limits.
If missed, nobody can tell what was actually tested.
Signers who don’t work here R04
The reviewer and approver named on the reports aren’t in the company roster.
If missed, the approvals can’t be traced to real people.
The wrong author R05
The listed author is a stability scientist, while the documents belong to a validation engineer.
If missed, authorship of key studies is unexplained.
Cites a document that doesn’t exist R07
A table cites document PROC-COMP-014 for tubing, but no such document exists anywhere.
If missed, a key claim rests on nothing.
Caught
Reports cite plans that aren’t on file R01
All three reports say an approved protocol defined the study, but no protocol exists for any of them, unlike the filter studies.
If missed, the studies can’t be shown to have followed a pre-agreed plan.
Three reports look copy-pasted R02
The reports share the same approval dates and the same wording for their observations, instead of reading like separate studies.
If missed, an inspector suspects the records were manufactured.
Cites an unrelated lab event R06
Every report mentions a discarded stability-lab run as having “no impact”, though it has nothing to do with these studies.
If missed, boilerplate is mistaken for real evidence.
The “result” figure is a recycled diagram R08
The IV-set report’s “representative figure” is the same generic process diagram printed earlier in the report, not a result.
If missed, a diagram passes for evidence.
Stay on the right subject R09
The job is the registered bag system. The proposed wrapper change is a separate issue and shouldn’t become the main finding.
If missed, the review drifts to a different question and misses its own.
Every model on the same job
One attempt each, same assignment and checklist, so treat small gaps as noise.
Submitted document
AVI-401_ccs_validation_records_check.docx
Talk to usRequest the full Biopharma Bench V0.1 — company environments and run receipts: team@raycaster.ai